DK0918469T3 - Fremgangsmåder og præparater til at øge den vævsanaerobe arbejdskapacitet - Google Patents
Fremgangsmåder og præparater til at øge den vævsanaerobe arbejdskapacitetInfo
- Publication number
- DK0918469T3 DK0918469T3 DK97937786T DK97937786T DK0918469T3 DK 0918469 T3 DK0918469 T3 DK 0918469T3 DK 97937786 T DK97937786 T DK 97937786T DK 97937786 T DK97937786 T DK 97937786T DK 0918469 T3 DK0918469 T3 DK 0918469T3
- Authority
- DK
- Denmark
- Prior art keywords
- beta
- creatine
- alanine
- preparations
- methods
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title 1
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 abstract 10
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 abstract 10
- 229940000635 beta-alanine Drugs 0.000 abstract 5
- 229960003624 creatine Drugs 0.000 abstract 5
- 239000006046 creatine Substances 0.000 abstract 5
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 4
- 238000009825 accumulation Methods 0.000 abstract 2
- 229960002885 histidine Drugs 0.000 abstract 2
- 210000002381 plasma Anatomy 0.000 abstract 2
- 230000036470 plasma concentration Effects 0.000 abstract 2
- 108010087806 Carnosine Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000037406 food intake Effects 0.000 abstract 1
- 238000001802 infusion Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Husbandry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9616910.7A GB9616910D0 (en) | 1996-08-12 | 1996-08-12 | A method of increasing ›-alanylihistidine pipetide synthesis and accumulation in humans and animals |
| GBGB9621914.2A GB9621914D0 (en) | 1996-08-12 | 1996-10-21 | A method to simultaneously increase ›-alanylhistidine dipeptides and creatine in bodily tissues of humans and animals |
| PCT/IB1997/001117 WO1998006278A1 (en) | 1996-08-12 | 1997-08-12 | Methods and compositions for increasing the anaerobic working capacity in tissues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0918469T3 true DK0918469T3 (da) | 2003-02-10 |
Family
ID=26309862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97937786T DK0918469T3 (da) | 1996-08-12 | 1997-08-12 | Fremgangsmåder og præparater til at øge den vævsanaerobe arbejdskapacitet |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0918469B1 (da) |
| JP (1) | JP4439019B2 (da) |
| CN (1) | CN1268234C (da) |
| AT (1) | ATE208144T1 (da) |
| AU (1) | AU4029397A (da) |
| CA (1) | CA2263184C (da) |
| DE (1) | DE69708109T2 (da) |
| DK (1) | DK0918469T3 (da) |
| WO (1) | WO1998006278A1 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965596A (en) | 1997-08-12 | 1999-10-12 | Harris; Roger | Methods and compositions for increasing the anaerobic working capacity in tissue |
| US7504376B2 (en) | 1996-08-12 | 2009-03-17 | Natural Alternatives International | Methods and compositions for increasing the anaerobic working capacity in tissues |
| JPH11322617A (ja) * | 1998-05-07 | 1999-11-24 | Tokiwa Yakuhin Kogyo Kk | チキンまたはカキ抽出物を含有する胃潰瘍予防用または治療用の医薬組成物 |
| EP1051914A1 (de) * | 1999-05-08 | 2000-11-15 | DSM Fine Chemicals Austria GmbH | Verwendung von Kreatin als Futterzusatz |
| JP4873778B2 (ja) * | 2000-12-04 | 2012-02-08 | 焼津水産化学工業株式会社 | 抗疲労剤 |
| US6855727B2 (en) * | 2000-12-04 | 2005-02-15 | Yaizu Suisankagaku Industry Co., Ltd. | Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect |
| JP2010150263A (ja) * | 2003-04-10 | 2010-07-08 | Natural Alternatives Internatl | 組織における無酸素性作業能力を高めるための方法及び組成物 |
| EP3081215B9 (en) * | 2005-05-23 | 2020-08-19 | Natural Alternatives International, Inc. | Compositions and methods for the sustained release of beta-alanine |
| CN105963299B (zh) * | 2016-04-25 | 2018-09-18 | 南京农业大学 | 一种渔用糖代谢调控物及其制备方法与应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54159393A (en) * | 1978-06-08 | 1979-12-17 | Ajinomoto Co Inc | Polyamino acid-coated activated carbon |
| JPS6016934A (ja) * | 1983-07-06 | 1985-01-28 | Kaneshiro Nagai | 抗腫瘍剤 |
| EP0436611A4 (en) * | 1988-09-28 | 1992-03-11 | Peptide Technology Ltd | Compound and method for the retardation of collagen cross-linking |
| JPH0395125A (ja) * | 1989-05-23 | 1991-04-19 | Otsuka Pharmaceut Co Ltd | カルシウム代謝改善剤 |
| IT1240336B (it) * | 1990-03-21 | 1993-12-07 | Setra | Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica |
| JP2873493B2 (ja) * | 1990-08-09 | 1999-03-24 | 理化学研究所 | 血糖調節剤 |
| JP2873497B2 (ja) * | 1990-09-03 | 1999-03-24 | 理化学研究所 | 脂質代謝調節剤 |
| JPH0624976A (ja) * | 1992-07-10 | 1994-02-01 | Rikagaku Kenkyusho | 輸液用組成物 |
-
1997
- 1997-08-12 AU AU40293/97A patent/AU4029397A/en not_active Abandoned
- 1997-08-12 DK DK97937786T patent/DK0918469T3/da active
- 1997-08-12 CN CNB971986029A patent/CN1268234C/zh not_active Expired - Lifetime
- 1997-08-12 JP JP50954698A patent/JP4439019B2/ja not_active Expired - Lifetime
- 1997-08-12 AT AT97937786T patent/ATE208144T1/de active
- 1997-08-12 WO PCT/IB1997/001117 patent/WO1998006278A1/en active IP Right Grant
- 1997-08-12 EP EP97937786A patent/EP0918469B1/en not_active Expired - Lifetime
- 1997-08-12 DE DE69708109T patent/DE69708109T2/de not_active Expired - Lifetime
- 1997-08-12 CA CA002263184A patent/CA2263184C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP4439019B2 (ja) | 2010-03-24 |
| DE69708109T2 (de) | 2002-08-01 |
| CN1237881A (zh) | 1999-12-08 |
| ATE208144T1 (de) | 2001-11-15 |
| CA2263184C (en) | 2008-06-03 |
| AU4029397A (en) | 1998-03-06 |
| EP0918469A1 (en) | 1999-06-02 |
| CA2263184A1 (en) | 1998-02-19 |
| WO1998006278A1 (en) | 1998-02-19 |
| EP0918469B1 (en) | 2001-11-07 |
| JP2000516464A (ja) | 2000-12-12 |
| CN1268234C (zh) | 2006-08-09 |
| DE69708109D1 (de) | 2001-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE330468T1 (de) | Lösung zur evaluierung und konservierung | |
| BG106825A (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
| EA200001154A1 (ru) | Твердые композиции, содержащие производные гамма-аминомасляной кислоты, и способ их получения | |
| ATE312635T1 (de) | Ventilanordnung | |
| DE69710065D1 (de) | Androsten-derivate | |
| HUP9700567A1 (hu) | Hatóanyagként dikambát és kinolinil-oxi-alkánsav-származékot tartalmazó herbicid kombináció és eljárás alkalmazására | |
| RU94022017A (ru) | Способ лечения акне или псевдофолликулита бороды, способ получения композиции, применение ингибитора фермента орнитиндекарбоксилазы для лечения акне или псевдофолликулита бороды | |
| DE60137635D1 (de) | Verwendung von allopurinol zur behandlung von bluthochdruck | |
| DE69116380D1 (de) | Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit | |
| DK0918469T3 (da) | Fremgangsmåder og præparater til at øge den vævsanaerobe arbejdskapacitet | |
| EA200100791A1 (ru) | Ингибиторы аминотрансфераз, зависимых от аминокислот с разветвленной цепью, и их применение в лечении диабетической ретинопатии | |
| NO982721L (no) | Preserverende oppl°sning | |
| ES2137125A1 (es) | La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal. | |
| PL339073A1 (en) | Derivatives of benzoxazine and benzothiazine and their application in therapeutic agents | |
| GEP20043231B (en) | Resorcinol Composition | |
| EP0761214A3 (en) | N,N-disubstituted anilines or alkylamines as singlet oxygen quenchers, topical compositions comprising them | |
| TR200202110T2 (tr) | "5-[{6-(2-Flüore benzil) oksi-2-naftil}metil]-2,4-tiyazolidin dion kristalleri" | |
| LU90993I2 (fr) | Xigris-drotrécogine alfa(activée) et ses dérivés pharmaceutiquement acceptables | |
| DE69734349D1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
| KR100348888B1 (en) | Method for relieving violence and spare diet of estrous deer and method for promoting growth of antlers thereof | |
| NZ503027A (en) | Use of rifamycin derivative for treating mastitis in a domestic animal | |
| EA200100477A1 (ru) | Фармацевтическая композиция тнр и эналаприла | |
| SE9904132D0 (sv) | Pharmaceutical composition for treatment of diarrhea | |
| ATE252902T1 (de) | Verwendung von calciumkanalanantagonisten zur behandlung von herz-, nieren-, magen-und darmkrankheiten sowie bluthochdruck | |
| AU2002232755A1 (en) | Felodipine transdermal device and methods |